original ) (raw )Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
Blood Cancer Discovery
View PDFchevron_right
Technological Challenges for Management of Genetic Complexities of Myelodysplastic Syndromes
Nitin Kadam
MGM Journal of Medical Sciences, 2019
View PDFchevron_right
Supplementary Table S5 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
View PDFchevron_right
Supplementary Table S8 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
2023
View PDFchevron_right
Moving Toward a Cure for Myeloma
Ajay Nooka
American Society of Clinical Oncology Educational Book
View PDFchevron_right
The EHA Research Roadmap: Normal Hematopoiesis
Lesley Forrester
HemaSphere, 2021
View PDFchevron_right
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
Giulia Falconi
2021
View PDFchevron_right
The Evolving Landscape: Exploring the Future of Myelodysplastic Syndrome Treatment with Dr. Rami Komrokji
Sean Jackewicz
Cancers
View PDFchevron_right
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Akshar Patel
Nature Genetics, 2020
View PDFchevron_right
Perspectives Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Mohamed Gaber
View PDFchevron_right
Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data
Alessandro Vannucchi
OncoTargets and Therapy
View PDFchevron_right
Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis
Mikayla Thompson
American Journal of Hematology, 2022
View PDFchevron_right
Multiple Myeloma Education: Results From the ACE Program’s Digital, Serial Learning Approach
Beth Faiman
Clinical Journal of Oncology Nursing, 2018
View PDFchevron_right
DNA damage check points prevent leukemic transformation in myelodysplastic syndrome
Masayuki Nagasawa
Leukemia, 2007
View PDFchevron_right
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
Andrew Spencer
BMC medical research methodology, 2016
View PDFchevron_right
Myeloma: A Lot of Progress, Still a Long Way to Go
Gabor Mikala
Cancers, 2021
View PDFchevron_right
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing
Chad Vanderbilt
The Journal of Molecular Diagnostics, 2021
View PDFchevron_right
Supplementary Table S7 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
View PDFchevron_right
Supplementary Table S2 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
2023
View PDFchevron_right
The Danish National Multiple Myeloma Registry
Peter Gimsing
Clinical Epidemiology, 2016
View PDFchevron_right
One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience
Aref Al-kali
Mayo Clinic Proceedings, 2012
View PDFchevron_right
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
N. Patten
Blood, 2014
View PDFchevron_right
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
David Dingli
Leukemia, 2007
View PDFchevron_right
A European strategy for targeted education in hematology
Janet Strivens
Haematologica, 2013
View PDFchevron_right
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
marie c bene
Haematologica, 2020
View PDFchevron_right
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients
Anna Durinikova
British Journal of Haematology, 2019
View PDFchevron_right
Identifying Professional Education Gaps and Barriers in Multiple Myeloma Patient Care: Findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee
Marie Recine
Clinical Lymphoma, Myeloma & Leukemia, 2014
View PDFchevron_right
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting
Maria Rosaria Pascale
Blood Advances
View PDFchevron_right
Supplementary Information from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Sasi Arunachalam
2023
View PDFchevron_right
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes
Georgina Daher-Reyes
Blood advances, 2018
View PDFchevron_right
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
William Figg
Blood advances, 2017
View PDFchevron_right
Exploring the boundaries of precision haemato-oncology : The case of FLT3 length mutated acute myeloid leukaemia
Caroline Engen
2020
View PDFchevron_right